Growth strategy
This year, Nycomed begins construction of a pharmaceuticals
production plant in Yaroslavl,
Russia. With an investment of up to €75 million,
it is expected to open in 2014. The company
has 16 facilities in 12 countries, so the new
plant will add to its standing as a global player.
Nycomed’s new facility will produce medicines
for
the local market in the Commonwealth of
Independent States including Russia (Russia-CIS),
which contributes 10% to Nycomed’s turnover
and plays an
important role in the company’s growth strategy.
The plant,
which is situated roughly 280 kilometres from
Moscow,
meets the current good manufacturing practice
(CGMP)
requirements and local regulations.
Versatile supplier
The facility is designed to manufacture liquid
sterile
products (ampoules and vials) as well as solid
medicines
(tablets). Liquid production includes solution
preparation,
washing of ampoules, sterilisation, filling and
inspection.
Solid production encompasses all stages, from
mixing and
granulation through to compression and coating.
In addition,
packaging lines for both solids and liquids are
incorporated.
Nycomed plans to make products that are important
for the
local market, such as Cardiomagnyl, Actovegin,
calcium
and Warfarin.
The aforementioned products are currently manufactured
in three of four competence centres, located in
Austria and
Germany. Each of them has considerable experience
in
sterile or solid production. The competence centre
for solids
is located in Oranienburg near Berlin; those for
sterile
products in Singen near the Lake of Constance
and in Linz,
the biggest industrial city in Upper Austria.
The sterile liquid production plants are specialised
in
filling glass ampoules and vials in large quantities,
as well as
in filling syringes.
Biological centre
Employing an international team of 500 people,
Nycomed
Austria in Linz is also the competence centre
for products of
biological origin, with great expertise in processing
material
of animal or human origin. At Linz, more than
3,800 tons
of calves’ blood per year are handled in
order to produce
Actovegin. In the future, Nycomed Austria will
be permitted
to handle narcotic drugs and drug substances.
The site in Oranienburg, which this year celebrates
125 years in pharma manufacture, offers compressed
technologies. It has undergone constant improvements
with
new buildings being installed just a few years
ago, so today
the company can offer worldwide production, approved
by
several authorities globally.
The site in Singen also offers cutting-edge production
in steriles and semi-solids, with more than 700
people
working every day to deliver a committed effort
to
Nycomed and its clients.
Contract manufacturing
At Nycomed, providing the highest quality is a
matter of
course; safety and convenience are its maxims.
Besides
producing its own brands, the company offers its
competence
and experience in manufacturing all these technologies
to
external partners.
| |
"Nycomed offers expertise
not only in scientific matters but also
in assisting clients to understand their
target markets for the supply and distribution
of products."
|
Looking back on more than 40 years of experience
in the contract manufacturing business, Nycomed
is proud to serve a client base of customers from
emerging companies to big pharma. Its service
covers the whole supply chain from careful sourcing
of raw materials and efficient production of the
bulk material to specific secondary packaging
and the timely delivery of the final product.
Its sites are an integral part of a global contract
manufacturing
organisation, currently consisting of eight sites,
which offer
the whole range of pharmaceutical technologies
from solid to
liquid preparations.
Tailor-made services
In total Nycomed operates 16 pharma production
facilities
in 12 countries; these sites are meeting the highest
international quality standards. Staying in contact
with its
clients is part of the organisation’s understanding
of
providing complete customer care: it tailors its
services
towards specific customers and tasks. Nycomed
offers
expertise not only in scientific matters but also
in assisting
clients to understand their target markets for
the supply and
distribution of products.
Partnership plays a vital role in all its operational
activities
and helps to guarantee that products reach exactly
the right
customers in the most efficient manner possible.
If you would
like to know more about Nycomed, visit Stand no
4G40, Hall
4.0, at the ICSE Europe 2010 fair, 5-7 October
2010, in Paris
Nord Villapinte Exhibition Centre, Paris, France.
|
